Research Program and Theme
- Program: Cancer Engineering and Biological Systems
- Theme: Mechanistic and Quantitative Biology
Research Focus
Bruce A. Bunnell leads a translational research program centered on adult stem cells, with a primary focus on mesenchymal stem cells (MSCs) and their therapeutic potential across a range of degenerative and inflammatory diseases. His work advances MSC-based interventions for conditions including multiple sclerosis, osteoarthritis, rotator cuff injury, chronic wound repair, and lipedema, with several efforts progressing toward human clinical trials. In parallel, Dr. Bunnell investigates the role of MSCs within the tumor microenvironment, examining how these cells influence cancer progression, immune modulation, and the intersection between obesity and cancer biology.
Complementing these efforts, Dr. Bunnell’s laboratory develops innovative tissue engineering strategies that integrate lab-generated or decellularized native scaffolds with stem cells to reconstruct functional tissues and organs. He also pioneers microphysiological systems, including a human knee joint model, to recapitulate complex tissue interactions, enabling mechanistic studies of disease and preclinical evaluation of emerging therapies. Collectively, his research bridges fundamental stem cell biology with clinical translation, aiming to advance regenerative medicine and improve outcomes in both degenerative diseases and cancer.
Other Campus Affiliations
- Head, Biomedical and Translational Sciences
- Visiting Professor, Biomedical and Translational Sciences
- Visiting Professor, Bioengineering